PT 141 how much to take is a common question, and the approved answer for most people is 1.75 mg by injection once per day, up to eight doses per month.
For the FDA-approved version of PT-141 — bremelanotide, sold as Vyleesi — the standard dose is 1.75 mg injected subcutaneously into the thigh or abdomen at least 45 minutes before anticipated sexual activity. That is the only dose the FDA has reviewed and approved, and it should not be repeated within 24 hours or used more than eight times per month. Compounded injections and nasal sprays sold online are not FDA-approved, and no official dosing standard exists for those products.
PT-141 Dosing at a Glance
The amount you take depends heavily on the form you use. The table below compares commonly reported doses across delivery methods.
| Form | Commonly reported dose | FDA status | Key notes |
|---|---|---|---|
| Vyleesi auto-injector (subcutaneous) | 1.75 mg | Approved for premenopausal women with hypoactive sexual desire disorder | One dose per 24 hours; maximum 8 doses per month |
| Compounded PT-141 injection | 1–2 mg | Not approved | Based on small trials; no potency or purity oversight |
| Nasal spray | 10–20 mg reported in older studies | Not approved | Absorption varies widely between products |
| Sublingual or topical | Not standardized | Not approved | Very little reliable data on absorption or effect |
Why 1.75 mg Is the Number You See Most
Bremelanotide's approval came from two Phase 3 trials in premenopausal women. Researchers tested 0.75 mg, 1.25 mg, and 1.75 mg doses and found that 1.75 mg produced the largest improvement in desire and distress scores.
Higher amounts did not improve results. In earlier studies, doses of 2 mg and above were linked to more nausea, vomiting, and temporary blood pressure increases without meaningful added benefit. That is why the product label stops at 1.75 mg.
More is not better with PT-141. The approved dose is a ceiling, not a starting point to climb past.
What Changes How Much PT-141 You Take
Several variables shift the practical dose even when the label says 1.75 mg. Anyone researching how to take pt-141 should review these first.
- Route of administration. An injection delivers the full dose; nasal and sublingual routes absorb unpredictably.
- Cardiovascular health. PT-141 can raise blood pressure briefly, so uncontrolled hypertension or known heart disease is a reason to avoid it.
- Other medications. Interactions with blood pressure drugs, MAOIs, and other vasoactive compounds can matter.
- Sex and hormonal status. Approval covers premenopausal women; dosing evidence in men and postmenopausal women is thinner.
- Reconstitution math. If you are mixing a lyophilized vial, questions like how much bacteriostatic water to mix with pt-141 change the concentration, not the total milligrams you draw into the syringe.
- Frequency. Daily use is not the regimen; the label allows one dose per day and no more than eight doses per month.
Timing: When It Kicks In and How Long It Lasts
Patients often ask pt-141 how long does it take to work. After a subcutaneous injection, effects usually begin within 45 minutes and can last for two to three hours.
Taking a dose with food may slow absorption slightly. Alcohol and very heavy meals are common culprits behind a dose that does not seem to work.
Compounded and nasal versions have no reliable timeline, because the amount actually absorbed into the bloodstream is unknown.
Nasal Sprays and Compounded Products
Nasal bremelanotide was studied years ago but never approved for sale. Reported intranasal doses ranged from roughly 10 mg to 20 mg, with inconsistent results and more nausea at higher amounts.
Instructions for how to use pt-141 nasal spray are not standardized. Vendors set their own concentrations, spray volumes, and schedules, and independent lab testing of these products often finds that the label does not match the contents.
Online interest in how to make pt-141 nasal spray is also high, but homemade preparations carry real risks: contamination, inaccurate dosing, and no sterility guarantee. There is no safe do-it-yourself recipe.
Side Effects and Safety
Nausea is the most common side effect, reported by roughly 40% of participants in clinical trials. Other effects include flushing, headache, vomiting, injection-site reactions, and a short-lived rise in blood pressure.
Repeated use can cause darkening of the gums, face, or other skin areas, a condition called focal hyperpigmentation. This effect may not fully reverse after you stop.
- Do not use PT-141 if you have uncontrolled high blood pressure or known cardiovascular disease.
- Avoid combining it with MAOIs or other drugs that affect blood pressure unless a clinician is supervising.
- Do not exceed one dose in 24 hours, and do not use more than eight doses per month.
PT-141 is a prescription product in the United States, and using compounded or research-grade versions means accepting unknown purity and potency. Talk to a healthcare professional before starting, especially if you take blood pressure medication or have any heart condition.
Bottom Line
The FDA-approved dose of PT-141 is 1.75 mg by subcutaneous injection, no more than once every 24 hours and no more than eight times per month. There is no approved dose for nasal sprays, compounded vials, or sublingual products, and larger amounts have not been shown to work better.
If you are considering PT-141, get a prescription and medical guidance rather than guessing at a number from a forum post.
Frequently Asked Questions
How much PT-141 should I take for my first dose?
The only FDA-approved dose is 1.75 mg, injected subcutaneously into the thigh or abdomen at least 45 minutes before sexual activity. No approved starting dose exists for compounded injections or nasal sprays, so a clinician should guide any use of those products.
Can you take PT-141 two days in a row?
The label allows one dose per 24 hours, so doses on consecutive days are permitted as long as you stay under eight doses per month. Using it daily is not recommended and increases the risk of nausea and skin hyperpigmentation.
Does PT-141 work for men?
PT-141 is FDA-approved only for premenopausal women with hypoactive sexual desire disorder. Some small studies in men showed modest improvements in erectile function, but it is not approved for that use and a reliable dose for men has not been established.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.